23.46
0.03 (0.13%)
| Penutupan Terdahulu | 23.43 |
| Buka | 23.44 |
| Jumlah Dagangan | 546,477 |
| Purata Dagangan (3B) | 312,012 |
| Modal Pasaran | 151,602,736 |
| Harga / Pendapatan (P/E Ke hadapan) | 56.50 |
| Harga / Jualan (P/S) | 1.48 |
| Harga / Buku (P/B) | 2.01 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Aug 2026 |
| Margin Keuntungan | -25.72% |
| Margin Operasi (TTM) | -48.87% |
| EPS Cair (TTM) | -0.320 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -18.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.12% |
| Nisbah Semasa (MRQ) | 1.66 |
| Aliran Tunai Operasi (OCF TTM) | 6.36 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 16.48 M |
| Pulangan Atas Aset (ROA TTM) | -6.60% |
| Pulangan Atas Ekuiti (ROE TTM) | -25.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Assertio Holdings, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | -0.50 |
|
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.52% |
| % Dimiliki oleh Institusi | 26.92% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |